{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:35:12Z","timestamp":1793115312585,"version":"4.5.0"},"reference-count":25,"publisher":"American Society of Hematology","issue":"20","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,27]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Although studies on HLA-haploidentical hematopoietic stem cell transplant (HSCT) for high-risk acute myeloid leukemia (AML) showed that regulatory T-lymphocyte (Treg) and conventional T-lymphocyte (Tcon) immunotherapy prevents graft-versus-host disease (GVHD) while exerting T-cell\u2013dependent graft-versus-leukemia (GVL) effect, its mechanism is not well known. The present study clarifies the mechanisms underlying this finding. In a xenogenic immunotherapy model, nonobese diabetic-scidIl2rgtm mice were engrafted with human primary AML and were treated with allogeneic human peripheral blood Tregs followed by Tcons. Treg\/Tcon immunotherapy cleared leukemia without causing GVHD. Peripheral blood Tregs are largely CD45RO+ and express low levels of CXCR4 bone marrow (BM) homing receptor. They localized in peripheral tissues (ie, liver, gut), but not in the BM. Consequently, in the BM, Tcon effector function was not downregulated and indeed Tcons killed leukemic cells. In contrast, in peripheral tissues, Tcons showed no alloreactivity suggesting that their effector function had been downregulated by the Tregs. Thus, the GVL effect without GVHD was caused by the migratory features of peripheral blood Tregs. These data were confirmed in a major histocompatibility complex\u2013mismatched BM transplant model using H-2b mice as recipients and H-2d mice as donors. Remarkably, in patients receiving T-cell\u2013depleted haploidentical HSCT with Treg\/Tcon immunotherapy, the infused Tregs were not found in the BM in the first month after transplant. In contrast, donor Tcons homed to the BM where they exerted leukemic-cell killing. In conclusion, to our knowledge, for the first time, we show the mechanism whereby immunotherapy with Tregs\/Tcons prevents GVHD while preserving GVL in murine transplant models and in patients with leukemia who underwent transplantation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025017997","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:28:36Z","timestamp":1787164116000},"page":"7023-7035","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["CXCR4-dependent migratory differences between peripheral Tregs and Tcons preserve GVL while limiting GVHD after HSCT"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9997-2719","authenticated-orcid":false,"given":"Loredana","family":"Ruggeri","sequence":"first","affiliation":[{"name":"1Hematology Division, Azienda Ospedaliera di Perugia, 'Santa Maria della Misericordia', Hospital, 06132 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pierini","sequence":"additional","affiliation":[{"name":"2Hematology and Clinical Immunology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Urbani","sequence":"additional","affiliation":[{"name":"2Hematology and Clinical Immunology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0175-0490","authenticated-orcid":false,"given":"Sara","family":"Ciardelli","sequence":"additional","affiliation":[{"name":"1Hematology Division, Azienda Ospedaliera di Perugia, 'Santa Maria della Misericordia', Hospital, 06132 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3930-2957","authenticated-orcid":false,"given":"Rachele","family":"Del Sordo","sequence":"additional","affiliation":[{"name":"3Section of Pathological Anatomy, Department of Medicine and Surgery, University of Perugia, Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Sola","sequence":"additional","affiliation":[{"name":"1Hematology Division, Azienda Ospedaliera di Perugia, 'Santa Maria della Misericordia', Hospital, 06132 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Zei","sequence":"additional","affiliation":[{"name":"1Hematology Division, Azienda Ospedaliera di Perugia, 'Santa Maria della Misericordia', Hospital, 06132 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Iacucci Ostini","sequence":"additional","affiliation":[{"name":"1Hematology Division, Azienda Ospedaliera di Perugia, 'Santa Maria della Misericordia', Hospital, 06132 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Saldi","sequence":"additional","affiliation":[{"name":"4Oncological Radiotherapy Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Maria","family":"Adamo","sequence":"additional","affiliation":[{"name":"1Hematology Division, Azienda Ospedaliera di Perugia, 'Santa Maria della Misericordia', Hospital, 06132 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Mancusi","sequence":"additional","affiliation":[{"name":"2Hematology and Clinical Immunology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7715-2832","authenticated-orcid":false,"given":"Karim Enrico","family":"Jardini","sequence":"additional","affiliation":[{"name":"1Hematology Division, Azienda Ospedaliera di Perugia, 'Santa Maria della Misericordia', Hospital, 06132 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eni","family":"Hoxha","sequence":"additional","affiliation":[{"name":"2Hematology and Clinical Immunology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"Viglione","sequence":"additional","affiliation":[{"name":"2Hematology and Clinical Immunology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Sembenico","sequence":"additional","affiliation":[{"name":"2Hematology and Clinical Immunology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3498-2389","authenticated-orcid":false,"given":"Francesco","family":"Zorutti","sequence":"additional","affiliation":[{"name":"2Hematology and Clinical Immunology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1394-3724","authenticated-orcid":false,"given":"Susanta","family":"Hui","sequence":"additional","affiliation":[{"name":"5Department of Radiation Oncology, Beckman Research Institute, City of Hope, Duarte, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6701-4023","authenticated-orcid":false,"given":"Mauro","family":"Di Ianni","sequence":"additional","affiliation":[{"name":"6Department of Medicine and Aging Sciences, \u201cGabriele d'Annunzio\u201d University of Chieti-Pescara, Pescara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Falzetti","sequence":"additional","affiliation":[{"name":"2Hematology and Clinical Immunology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9139-1729","authenticated-orcid":false,"given":"Maria Paola","family":"Martelli","sequence":"additional","affiliation":[{"name":"2Hematology and Clinical Immunology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1623-0148","authenticated-orcid":false,"given":"Cristina","family":"Mecucci","sequence":"additional","affiliation":[{"name":"2Hematology and Clinical Immunology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9749-649X","authenticated-orcid":false,"given":"Cynthia","family":"Aristei","sequence":"additional","affiliation":[{"name":"4Oncological Radiotherapy Section, Department of Medicine and Surgery, University of Perugia, Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Carotti","sequence":"additional","affiliation":[{"name":"1Hematology Division, Azienda Ospedaliera di Perugia, 'Santa Maria della Misericordia', Hospital, 06132 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo Fabrizio","family":"Martelli","sequence":"additional","affiliation":[{"name":"2Hematology and Clinical Immunology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Velardi","sequence":"additional","affiliation":[{"name":"2Hematology and Clinical Immunology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"2026102711122063900_bib1","author":"Appelbaum","year":"2009","edition":"4th ed"},{"issue":"11","key":"2026102711122063900_bib2","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1182\/blood-2010-04-278317","article-title":"Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis","volume":"116","author":"Gupta","year":"2010","journal-title":"Blood"},{"key":"2026102711122063900_bib3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/9781444303537.ch46","volume-title":"Thomas\u2019 Hematopoietic Cell Transplantation","author":"Anasetti","year":"2009","edition":"4th ed"},{"issue":"19","key":"2026102711122063900_bib4","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1056\/NEJM197905103001902","article-title":"Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts","volume":"300","author":"Weiden","year":"1979","journal-title":"N Engl J Med"},{"issue":"3","key":"2026102711122063900_bib5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"issue":"4","key":"2026102711122063900_bib6","first-page":"583","article-title":"Graft-versus-leukemia in rat MHC-mismatched bone marrow transplantation is merely an allogeneic effect","volume":"15","author":"Kloosterman","year":"1995","journal-title":"Bone Marrow Transpl"},{"issue":"10","key":"2026102711122063900_bib7","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.2012.44.3523","article-title":"T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation","volume":"31","author":"Bashey","year":"2013","journal-title":"J Clin Oncol"},{"issue":"5","key":"2026102711122063900_bib8","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1182\/blood-2012-08-453399","article-title":"Haploidentical, unmanipulated, G-CSFprimed bone marrow transplantation for patients with high-risk hematologic malignancies","volume":"121","author":"Di Bartolomeo","year":"2013","journal-title":"Blood"},{"issue":"6","key":"2026102711122063900_bib9","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/MOH.0b013e3283582322","article-title":"Haploidentical hematopoietic stem cell transplantation with unmanipulated granulocyte colony stimulating factor mobilized marrow and blood grafts","volume":"19","author":"Chang","year":"2012","journal-title":"Curr Opin Hematol"},{"issue":"23","key":"2026102711122063900_bib10","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1182\/blood-2016-07-730564","article-title":"Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translation","volume":"128","author":"Mancusi","year":"2016","journal-title":"Blood"},{"issue":"3","key":"2026102711122063900_bib11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1084\/jem.20020399","article-title":"Donor-type CD4+ CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation","volume":"196","author":"Hoffmann","year":"2002","journal-title":"J Exp Med"},{"issue":"9","key":"2026102711122063900_bib12","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm915","article-title":"CD4+CD25+ regulatory T cells preserve graft versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation","volume":"9","author":"Edinger","year":"2003","journal-title":"Nat Med"},{"issue":"11","key":"2026102711122063900_bib13","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1172\/JCI17702","article-title":"Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus- leukemia","volume":"112","author":"Trenado","year":"2003","journal-title":"J Clin Invest"},{"issue":"4","key":"2026102711122063900_bib14","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1182\/blood-2014-03-564401","article-title":"HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse","volume":"124","author":"Martelli","year":"2014","journal-title":"Blood"},{"issue":"14","key":"2026102711122063900_bib15","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","article-title":"Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation","volume":"117","author":"Di Ianni","year":"2011","journal-title":"Blood"},{"issue":"5","key":"2026102711122063900_bib16","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1182\/bloodadvances.2020003739","article-title":"Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia","volume":"5","author":"Pierini","year":"2021","journal-title":"Blood Adv"},{"issue":"6","key":"2026102711122063900_bib17","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1182\/blood-2006-08-044529","article-title":"In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation","volume":"109","author":"Nguyen","year":"2007","journal-title":"Blood"},{"issue":"8","key":"2026102711122063900_bib18","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.4049\/jimmunol.0903781","article-title":"Different proliferative potential and migratory characteristics of human CD4+ regulatory T cells that express either CD45RA or CD45RO","volume":"184","author":"Booth","year":"2010","journal-title":"J Immunol"},{"key":"2026102711122063900_bib19","doi-asserted-by":"crossref","first-page":"1617528","DOI":"10.3389\/fimmu.2025.1617528","article-title":"A comprehensive welfare scoring system for graft versus host disease clinical assessment in humanised mouse models used for pharmaceutical research","volume":"16","author":"Nowak","year":"2025","journal-title":"Front Immunol"},{"issue":"7350","key":"2026102711122063900_bib20","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nature10160","article-title":"In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche","volume":"474","author":"Fujisaki","year":"2011","journal-title":"Nature"},{"key":"2026102711122063900_bib21","doi-asserted-by":"crossref","first-page":"570550","DOI":"10.3389\/fimmu.2020.570550","article-title":"Maturation and phenotypic heterogeneity of human CD4+ regulatory T cells from birth to adulthood and after allogeneic stem cell transplantation","volume":"11","author":"Matos","year":"2020","journal-title":"Front Immunol"},{"issue":"17","key":"2026102711122063900_bib22","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype","volume":"339","author":"Aversa","year":"1998","journal-title":"N Engl J Med"},{"issue":"15","key":"2026102711122063900_bib23","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1200\/JCO.2005.09.117","article-title":"Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse","volume":"23","author":"Aversa","year":"2005","journal-title":"J Clin Oncol"},{"key":"2026102711122063900_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1196\/annals.1349.010","article-title":"Hematopoietic stem cell transplantation across major genetic barriers: tolerance induction by megadose CD34 cells and other veto cells","volume":"1044","author":"Reisner","year":"2005","journal-title":"Ann N Y Acad Sci"},{"issue":"5562","key":"2026102711122063900_bib25","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/20\/7023\/2595326\/blooda_adv-2025-017997-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/20\/7023\/2595326\/blooda_adv-2025-017997-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:12:33Z","timestamp":1793113953000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/20\/7023\/570272\/CXCR4-dependent-migratory-differences-between"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":25,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2026,10,27]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025017997","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10,27]]},"published":{"date-parts":[[2026,10,16]]}}}